1. Home
  2. KYMR vs SPB Comparison

KYMR vs SPB Comparison

Compare KYMR & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • SPB
  • Stock Information
  • Founded
  • KYMR 2015
  • SPB 1906
  • Country
  • KYMR United States
  • SPB United States
  • Employees
  • KYMR N/A
  • SPB N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • SPB Industrial Machinery/Components
  • Sector
  • KYMR Health Care
  • SPB Miscellaneous
  • Exchange
  • KYMR Nasdaq
  • SPB Nasdaq
  • Market Cap
  • KYMR 2.1B
  • SPB 2.4B
  • IPO Year
  • KYMR 2020
  • SPB N/A
  • Fundamental
  • Price
  • KYMR $33.45
  • SPB $70.43
  • Analyst Decision
  • KYMR Buy
  • SPB Buy
  • Analyst Count
  • KYMR 13
  • SPB 6
  • Target Price
  • KYMR $56.69
  • SPB $103.00
  • AVG Volume (30 Days)
  • KYMR 695.8K
  • SPB 405.9K
  • Earning Date
  • KYMR 05-01-2025
  • SPB 05-08-2025
  • Dividend Yield
  • KYMR N/A
  • SPB 2.66%
  • EPS Growth
  • KYMR N/A
  • SPB N/A
  • EPS
  • KYMR N/A
  • SPB 4.12
  • Revenue
  • KYMR $47,072,000.00
  • SPB $2,971,900,000.00
  • Revenue This Year
  • KYMR $44.93
  • SPB $1.69
  • Revenue Next Year
  • KYMR N/A
  • SPB $2.16
  • P/E Ratio
  • KYMR N/A
  • SPB $17.13
  • Revenue Growth
  • KYMR N/A
  • SPB 2.56
  • 52 Week Low
  • KYMR $29.07
  • SPB $70.27
  • 52 Week High
  • KYMR $53.27
  • SPB $96.74
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 44.68
  • SPB 26.55
  • Support Level
  • KYMR $31.54
  • SPB $73.12
  • Resistance Level
  • KYMR $31.66
  • SPB $76.96
  • Average True Range (ATR)
  • KYMR 2.31
  • SPB 1.89
  • MACD
  • KYMR 0.37
  • SPB -0.34
  • Stochastic Oscillator
  • KYMR 51.20
  • SPB 1.59

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.

Share on Social Networks: